Shoichiro Sato

4.9k total citations
115 papers, 2.3k citations indexed

About

Shoichiro Sato is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shoichiro Sato has authored 115 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 48 papers in Neurology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shoichiro Sato's work include Acute Ischemic Stroke Management (51 papers), Intracerebral and Subarachnoid Hemorrhage Research (36 papers) and Neurosurgical Procedures and Complications (24 papers). Shoichiro Sato is often cited by papers focused on Acute Ischemic Stroke Management (51 papers), Intracerebral and Subarachnoid Hemorrhage Research (36 papers) and Neurosurgical Procedures and Complications (24 papers). Shoichiro Sato collaborates with scholars based in Japan, Australia and China. Shoichiro Sato's co-authors include Ḱazunori Toyoda, Kazuo Minematsu, Craig S. Anderson, Toshiyuki Uehara, John Chalmers, Thompson Robinson, Candice Delcourt, Hiroaki Naritomi, Chiaki Yokota and Xia Wang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Shoichiro Sato

112 papers receiving 2.3k citations

Peers

Countries citing papers authored by Shoichiro Sato

Since Specialization

Citations

This map shows the geographic impact of Shoichiro Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichiro Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichiro Sato more than expected).

Fields of papers citing papers by Shoichiro Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichiro Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichiro Sato. The network helps show where Shoichiro Sato may publish in the future.

Co-authorship network of co-authors of Shoichiro Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichiro Sato. A scholar is included among the top collaborators of Shoichiro Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichiro Sato. Shoichiro Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Donanemab in early symptomatic Alzheimer’s disease: results from the TRAILBLAZER-ALZ 2 long-term extension 2025 ·The Journal of Prevention of Alzheimer s Disease ·Jennifer A. Zimmer, John R. Sims, Cynthia Evans, Emel Serap Monkul Nery, Hong Wang, Alette M. Wessels, Giulia Tronchin, Shoichiro Sato, Lars Lau Rakêt, Scott W. Andersen, Christophe Sapin, (unknown), Ivelina Gueorguieva, Paul Ardayfio, Rashna Khanna, Dawn A. Brooks, Brandy R. Matthews, Mark A. Mintun	0
2	Donanemab in Japanese Patients with Early Alzheimer’s Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial 2024 ·Neurology and Therapy ·Shoichiro Sato, (unknown), (unknown), Sadao Katayama, Hideaki Katagiri, John R. Sims	8
3	Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan 2020 ·Journal of Stroke and Cerebrovascular Diseases ·Susumu Miyamoto, Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Yuji Murakawa, (unknown), Makiko Takeichi, Yoko Kidani, (unknown), (unknown), Shoichiro Sato, Satoshi Yamanaka	8
4	Who will benefit more from low-dose alteplase in acute ischemic stroke? 2019 ·International Journal of Stroke ·Xia Wang, Keon‐Joo Lee, Tom J. Moullaali, Beom Joon Kim, Qiang Li, Hee‐Joon Bae, Cheryl Carcel, Candice Delcourt, Hisatomi Arima, Shoichiro Sato, Thompson Robinson, Lili Song, Guofang Chen, Jie Yang, John Chalmers, Craig S. Anderson, Richard I. Lindley, Mark Woodward, (unknown)	9
5	Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings 2019 ·Journal of Thrombosis and Thrombolysis ·Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, (unknown), Yoko Kidani, (unknown), (unknown), Shoichiro Sato, Satoshi Yamanaka	45
6	Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study 2019 ·Cerebrovascular Diseases Extra ·Candice Delcourt, Cheryl Carcel, Danni Zheng, Shoichiro Sato, Hisatomi Arima, Sonu Bhaskar, Pierre Janin, Rustam Al‐Shahi Salman, Yongjun Cao, Shihong Zhang, Emma Heeley, Leo Davies, John Chalmers, Craig S. Anderson, (unknown)	13
7	Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal function 2019 ·Journal of Cardiology ·Jyoji Nakagawara, Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, Makiko Takeichi, Yoko Kidani, (unknown), (unknown), Shoichiro Sato, Satoshi Yamanaka	1
8	Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack 2019 ·Cerebrovascular Diseases ·Kazuo Minematsu, Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Susumu Miyamoto, Yuji Murakawa, Makiko Takeichi, Yoko Kidani, (unknown), (unknown), Shoichiro Sato, Satoshi Yamanaka	4
9	Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study 2017 ·Journal of the Neurological Sciences ·Sohei Yoshimura, Shoichiro Sato, Kenichi Todo, Yasushi Okada, Eisuke Furui, Takayuki Matsuki, Hiroshi Yamagami, Masatoshi Koga, Jun Takahashi, Kazuyuki Nagatsuka, Shoji Arihiro, Ḱazunori Toyoda	10
10	Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage 2016 ·Stroke ·Cheryl Carcel, Xia Wang, Shoichiro Sato, Christian Stapf, Else Charlotte Sandset, Candice Delcourt, Hisatomi Arima, Thompson Robinson, Pablo M. Lavados, John Chalmers, Craig S. Anderson	40
11	Abstract WMP85: Significance of Cerebral Small Vessel Disease in Acute Intracerebral Hemorrhage: The INTERACT2 Study [poster] 2016 ·Stroke ·Shoichiro Sato, Candice Delcourt, Emma Heeley, Hisatomi Arima, (unknown), Rustam Al‐Shahi Salman, Christian Stapf, (unknown), (unknown), Achala Vagal, Christopher Levi, Linda Davies, (unknown), Thompson Robinson, Pablo M. Lavados, Richard I. Lindley, John Chalmers, Craig S. Anderson	1
12	Associations with health-related quality of life after intracerebral haemorrhage: pooled analysis of INTERACT studies 2016 ·Journal of Neurology Neurosurgery & Psychiatry ·Candice Delcourt, Danni Zheng, Xiaoying Chen, Maree L. Hackett, Hisatomi Arima, Jun Hata, Emma Heeley, Rustam Al‐Shahi Salman, Mark Woodward, Yining Huang, Thompson Robinson, Pablo M. Lavados, Richard I. Lindley, Christian Stapf, Leo Davies, John Chalmers, Craig S. Anderson, Shoichiro Sato	21
13	Intravenous Nicardipine Dosing for Blood Pressure Lowering in Acute Intracerebral Hemorrhage: The Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage Study 2014 ·Journal of Stroke and Cerebrovascular Diseases ·Masatoshi Koga, Shoji Arihiro, Yasuhiro Hasegawa, Yoshiaki Shiokawa, Yasushi Okada, Kazumi Kimura, Eisuke Furui, Jyoji Nakagawara, Hiroshi Yamagami, Kazuomi Kario, Satoshi Okuda, Keisuke Tokunaga, (unknown), Junji Takasugi, Shoichiro Sato, Kazuyuki Nagatsuka, Kazuo Minematsu, Ḱazunori Toyoda	10
14	Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis 2012 ·Lara D. Veeken ·Takahisa Gono, Shoichiro Sato, Yasushi Kawaguchi, Masataka Kuwana, Masanori Hanaoka, Yasuhiro Katsumata, (unknown), S. Baba, Yuko Okamoto, Yuko Ota, Hisashi Yamanaka	245
15	Ocular ischemic syndrome improved by stent placement for stenosis at the orfice of the left common carotid artery 2011 ·Rinsho Shinkeigaku ·Yukako Yazawa, Shoichiro Sato, Ryo Itabashi, Eisuke Furui, (unknown), Yasushi Matsumoto, Satoru Fujiwara	1
16	Prospective multicentre cohort study of heparin‐induced thrombocytopenia in acute ischaemic stroke patients 2011 ·British Journal of Haematology ·Hiroyuki Kawano, Haruko Yamamoto, Shigeki Miyata, (unknown), Teruyuki Hirano, (unknown), (unknown), Jo‐Ann I. Sheppard, Theodore E. Warkentin, Akiko Kada, Shoichiro Sato, Sadahisa Okamoto, Kazuyuki Nagatsuka, Hiroaki Naritomi, Ḱazunori Toyoda, Makoto Uchino, Kazuo Minematsu	7
17	Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease 2011 ·Thrombosis Research ·Ryo Itabashi, Etsuro Mori, Eisuke Furui, Shoichiro Sato, Yukako Yazawa, Satoru Fujiwara	1
18	A Fe(3+)/DNA complex induces an anti-human immunodeficiency virus factor(s) in CD4+ lymphocyte cell lines. 1999 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Reiko Tsutsumi, Yoshie Miura, K. Sera, (unknown), Shoichiro Sato, L'vov Dk	1
19	A monoclonal antibody-based enzyme-linked immunosorbent assay of aflatoxin B1 in peanut products 1988 ·Mycotoxin Research ·Osamu Kawamura, Satoshi Nagayama, Shoichiro Sato, Keishi Ohtani, Ichiro Ueno, Yuji Ueno	20
20	Localization of angiotensin converting enzyme (Kininase II). I. Preparation of antibody heme octapeptide conjugates 1976 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Hideki Yotsumoto, Shoichiro Sato, Masabumi Shibuya	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact